Status:
WITHDRAWN
Analgesic Contribution of the Suprazygomatic Maxillary Nerve Block for Cleft Palate Surgery in Children
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Cleft Palate
Surgery
Eligibility:
All Genders
5-12 years
Phase:
NA
Brief Summary
This is a monocentric prospective randomized simple-blind designed study evaluating the superiority of the suprazygomatic maxillary nerve block in analgesia after cleft palate surgery compared with a ...
Detailed Description
Cleft palate is the most common congenital malformation and requires early surgery given the complications it generates. The surgical site involving the upper airways and the use of morphine are provi...
Eligibility Criteria
Inclusion
- children between 5 months and 12 years old
- weight \>5kg
- children undergoing cleft palate repair surgery with or without upper lip surgery
Exclusion
- inappropriate age
- weight \<5kg
- abnormal blood coagulation
- local anesthetic contraindication (including levobupivacaine, as well as any other associated treatment administered in this clinical study, including opioids, general anesthetics such as ketamine or propofol, paracetamol or corticosteroids)
- local infection
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04023825
Start Date
July 1 2019
End Date
July 1 2022
Last Update
March 23 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.